US2006173075A1PendingUtilityA1

P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents

Individually held — no corporate assignee on recordPriority: Apr 28, 2000Filed: Mar 2, 2006Published: Aug 3, 2006
Est. expiryApr 28, 2020(expired)· nominal 20-yr term from priority
A61P 37/06A61P 37/02A61P 43/00A61P 3/10A61P 29/00A61P 25/28C07C 323/36C07D 213/38C07D 231/12C07D 333/20C07D 249/08C07D 277/64C07D 237/14A61P 19/02C07D 213/64C07D 207/14C07D 277/28A61P 19/06C07D 213/74C07C 317/36C07D 233/56A61P 21/00C07D 237/12C07D 207/27
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to anti-inflammatory and analgesic compounds, especially to certain p-(sulfonyl)phenyl amino derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.

Claims

exact text as granted — not AI-modified
1 . A compound selected from the group of compounds represented by formula (I):  
     
       
         
         
             
             
         
       
     
     wherein: 
 A is —(CR 2 ) n — where n is 1, 2, or 3 and R is independently hydrogen or alkyl;  
 B is aryl or heteroaryl;  
 R 1  is alkyl, alkenyl, cyanoalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaralkyl, heterocyclyl, heterocyclylalkyl, heteroalkyl or alkylcarbonylalkyl;  
 R 2  is NR 13 R 14  wherein:  
 R 13  is hydrogen or alkyl;  
 R 14  is hydrogen, alkyl, alkenyl, acyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aralkyl, hydroxyalkyl, alkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, or aminoalkyl;  
 R 3  is hydrogen, alkyl, halo, nitro, cyano, hydroxy, alkoxy;  
 and pharmaceutically acceptable salts thereof.  
 
   
   
       2 . The compound of  claim 1 , wherein: 
 R 3  is hydrogen.    
   
   
       3 . The compound of  claim 2  wherein B is aryl.  
   
   
       4 . The compound of  claim 3  wherein B is optionally substituted phenyl.  
   
   
       5 . The compound of  claim 4  wherein R 1  is alkyl, cycloalkyl, cycloalkyl-alkyl, heterocyclyl, heterocyclylalkyl or heteroalkyl.  
   
   
       6 . The compound of  claim 5  wherein R 1  is heteroalkyl.  
   
   
       7 . The compound of  claim 6  wherein R 1  is alkylsulfonylalkyl.  
   
   
       8 . (canceled)  
   
   
       9 . The compound of  claim 1  wherein A is —(CH 2 )—.  
   
   
       10 . The compound of  claim 7  wherein R 13  and R 14  are hydrogen.  
   
   
       11 . The compound of  claim 10  wherein A is —(CH 2 )—.  
   
   
       12 . The compound of  claim 2  wherein B is heteroaryl.  
   
   
       13 . The compound of  claim 12  wherein R 1  is alkyl, cycloalkyl, cycloalkyl-alkyl, heterocyclyl, heterocyclylalkyl or heteroalkyl.  
   
   
       14 . The compound of  claim 13  wherein R 1  is heteroalkyl.  
   
   
       15 . The compound of  claim 14  wherein R 1  is alkylsulfonylalkyl.  
   
   
       16 - 17 . (canceled)  
   
   
       18 . The compound of  claim 15  wherein R 13  and R 14  are hydrogen.  
   
   
       19 . The compound of  claim 18  wherein A is —(CH 2 )—.  
   
   
       20 - 37 . (canceled)  
   
   
       38 . The compound of  claim 1  wherein: 
 R 1  is alkylsulfonylalkyl; and    B is aryl.    
   
   
       39 - 40 . (canceled)  
   
   
       41 . The compound of  claim 38 , wherein R 2  is NH 2 .  
   
   
       42 . The compound of  claim 41 , wherein A is —(CH 2 )—.  
   
   
       43 - 49 . (canceled)

Join the waitlist — get patent alerts

Track US2006173075A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.